Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 5/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155790 | 0.98 | IDO1 (0.60) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| Formaldehyde SCHEMBL28039021 | 0.93 | IDO1 (0.56) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| Butylamine SCHEMBL11459551 | 0.82 | IDO1 (0.46) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| Acrylic Acid SCHEMBL9668105 | 0.81 | MAPK1 (0.48) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL12603775 | 0.80 | AHR (0.50) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL3782085 | 0.80 | IDO1 (0.44) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL426435 | 0.79 | IDO1 (0.56) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL257058 | 0.78 | HTR2A (0.51) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL1047227 | 0.78 | IDO1 (0.60) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL30102510 | 0.78 | HTR2A (0.51) | IDO1MAPK1CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11035528-A | — | — | None | — | — | JP | disclosed |
| US-9175006-B2 | Compositions and methods for cyclofructans as separation agents | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-11-03 | — | — | US | disclosed |
| US-20110024292-A1 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2011-02-03 | — | — | US | disclosed |
| JP-H1135528-A | PRODUCTION OF BENZYLAMINE | DAICEL CHEM IND LTD | 1999-02-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110024292-A1 | COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS | PAICS, DCXR, PFAS | IDO1 1150/4885MAPK1 4106/4885CYP1A2 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.